Dysfonction érectile après prostatectomie radicale: Intérêt de la programmation des injections intracaverneuses avant l'intervention

Progres en Urologie

Volumn 9, Issue 3, 1999, Pages 483-488

  Lebret, Thierry ^a   Hervé, Jean Marie ^a   Yonneau, Laurent ^a   Colau, Alexandre ^a   Kassardjian, Zaréh ^a   Barré, Philippe ^a   Lugagne Delpon, Pierre Marie ^a   Botto, Henry ^a  

^a FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASOCONSTRICTOR AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; HUMAN; IMPOTENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PREOPERATIVE CARE; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; SEXUAL BEHAVIOR;

AGED; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEXUAL BEHAVIOR; VASOCONSTRICTOR AGENTS;

EID: 0033145853     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BUVAT J., COSTA P., MORLIER D., LECOCQ B., STEGMAN B., ALBRECHT D.: Double blind multicenterstudy comparing alprostatil alpha-cyclodextrin with moxisylyte chlorydrate in patients with chronic erectile dysfonction. J. Urol., 1998, 159, 116-119.
2. BUVAT J., LEMAIRE A, HERBAUT-BUVAT M.: Intracavernous pharmacotherapy: comparaison of Moxisylyte and Prostaglandine E1 for treatment of erectile dysfonction. Int. J. Impot. Res., 1996, 8, 41-46.
3. CANALE D., GIORGI P.M., LENCIONI R., MORELLI G., GASPERI M., MACCHIA E. Long term intracavernous self injection with prostaglandin E1 for treatment of erectile dysfunction. Int. J. Androl., 1996, 19, 28-32.
4. COLSON M.H. Prise en charge des dysfonctions érectiles par injections intracaverneuses. Sexologie, 1994, III, 54-61.
5. DE LA TAILLE A., DELMAS V., AMAR E., BOCCON-GIBOD L. Pourquoi les auto-injections intra-caverneuses sont-elles abandonnées à long terme? Prog. Urol., 1998, 8, 529-536.
6. DE LUCA V., PESCATORI ES., TAHER B., ZAMBOLIN T., GIAMBRONI L., FREGO E., COSCIANI CUNICO S.: Damage to the erectile function following radical pelvic surgery: prevalence of veno-occlusive dysfunction. Eur. Urol., 1996, 29, 36-40.
7. FLYNN R. J., WILLIAMS G. Long-term follow-up of patients with erectile dysfunction compensed on self injection with intracavernosal papaverine with or without phentolamine. Br. J. Urol., 1996, 78, 628-631.
8. FOWLER FJ., BARRY MJ., LU-YAO G, ROMAN A., WASSON J., WENNENBERG JE.: Patient-reported complications and follow-up treatment after radical prostatectomy. The national Medicare experience: 1988-1990 (updated June 1993). Urology, 42: 622-626, 1993.
9. GAYLIS FD., FRIEDEL WE., ARMASO A.: Radical retropubic prostatectomy outcomes at a community hospital [see comments]. J. Urol., 1998, 159, 167-171.
10. GIULIANO F., BLANCHET P., BANZET O., LANCRENON S., BENOIT G., JARDIN A. et le GFEA. Troubles de l'érection: efficacité et tolérance à 6 mois des auto-injections intracaverneuses d'alprostadil. Pres. Med., 1994, 23, 1516-1521.
11. IRWIN M.B., KATE E.J.: High attrition rate with intracavernous injection of prostaglandin E1 for impotency. Urology, 1994, 43, 84-87.
12. LUNDBERG M., OLSSON JO., KIHL B.: Long term experience of self injection therapy with prostaglandin E1 for erectile dysfunction. Scand. J. Urol. Nephrol., 1996, 30, 395-397.
13. MONTORSI F., GUAZZONI G., STRAMBI L.F., DA POZZO L.F., NAVA L., BARBIERI L., RIGATTI P, PIZZINI G., MIANI A.: Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J. Urol., 1997, 158, 1408-1410.
14. ROBINSON JW., DUFOUR MS., FUNG TS: Erectile functioning of men treated for prostate carcinoma. Cancer, 1997, 79, 538-44.
15. ROSSETTI SR., TERRONE C.: Quality of life in prostate cancer patients. Eur. Urol., 1996, 30, Suppl 1, 44-48, discussion 49.
16. SIDI A.A., REDDY P.K., CHEN K.K. Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence. J. Urol., 1988, 140, 293-294.
17. STACKL W., HASUN R., MARBERGER M. Intracavernous injection of prostaglandin E1 in impotent men. J. Urol., 1988, 140, 66-68.
18. SUDARAM C. P., THOMAS W., PRYOR L.E., SIDI A. A., BILLUPS K., PRYOR J.L., Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology, 1997, 49, 932-935.
19. VIRAG R., SHOUKRY K., FLORESCO J., NOLLET F., GRECO E. Intracavernous self injection of vasoactive drugs in the treatment of impotence: 8 year experience with 615 cases. J. Urol., 1991, 145, 287-293.
20. WALSH PC., PARTIN AW., APSTEIN JI.: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., 1994, 152, 1831.
21. WATTERS G.R., KEOGH E.J., EARLE C.M., CARATI C.J., WISNIEWSKI Z.T., TULLOCH A.G.S., LORD D.J. Experience in the management of erectile dysfunction using the intracavernosal self injection of vasoactive drugs. J. Urol., 1988, 140, 1417-1419.
22. WEISS J.N., BADLANI G.H., RAVALLI R., BRETTSCHNEIDER N. Reasons for high drop out rate with self injection therapy for impotence. Int. J. Impot. Res., 1994, 6, 171-174.